Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2981278 in Plaque Psoriasis
NCT03004846Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK2981278 in plaque psoriasis, sponsored by GSK. Started Feb 2017; status: completed.
02
Drugs
GSK2981278
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03004846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03004846.